Skip to main content
. 2019 Aug 15;200(4):493–506. doi: 10.1164/rccm.201808-1509OC

Table 2.

Summary of the Results of the Adjusted Logistic Regression and Cox Proportional Hazards Models Assessing the Association between Obstructive Sleep Apnea Symptom Subtypes and Cardiovascular Outcomes

Outcome Prevalent*
Incident
Incident + Recurrent
OR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
Cardiovascular disease            
 Overall adjusted comparison§ 0.141 <0.001 0.016
 ES vs. MinS 1.62 (0.91–2.91) 0.1032 2.28 (1.53–3.40) 0.0001 1.50 (1.08–2.09) 0.016
 ES vs. DS 2.28 (1.05–4.95) 0.0374 2.37 (1.40–4.01) 0.0013 1.81 (1.15–2.85) 0.0105
 ES vs. ModS 1.75 (1.01–3.04) 0.0475 2.23 (1.52–3.27) <0.0001 1.59 (1.16–2.18) 0.0037
 ModS vs. MinS 0.93 (0.59–1.46) 0.7498 1.02 (0.73–1.43) 0.8949 0.94 (0.72–1.23) 0.6652
 ModS vs. DS 1.30 (0.66–2.58) 0.4462 1.06 (0.66–1.71) 0.7989 1.13 (0.75–1.70) 0.5443
 DS vs. MinS 0.71 (0.36–1.43) 0.3386 0.96 (0.60–1.55) 0.8723 0.83 (0.55–1.25) 0.377
Coronary heart disease            
 Overall adjusted comparison§ 0.784 0.015 0.068
 ES vs. MinS 1.23 (0.62–2.42) 0.5592 1.85 (1.17–2.93) 0.0086 1.54 (1.02–2.32) 0.0383
 ES vs. DS 1.51 (0.63–3.62) 0.3568 1.99 (1.07–3.72) 0.0302 1.84 (1.03–3.27) 0.0385
 ES vs. ModS 1.09 (0.57–2.06) 0.8022 1.99 (1.28–3.10) 0.0022 1.61 (1.09–2.37) 0.0161
 ModS vs. MinS 1.13 (0.68–1.88) 0.6394 0.93 (0.63–1.37) 0.7089 0.96 (0.68–1.35) 0.8088
 ModS vs. DS 1.39 (0.66–2.93) 0.3865 1.00 (0.57–1.77) 0.9959 1.14 (0.68–1.93) 0.6169
 DS vs. MinS 0.81 (0.38–1.75) 0.5956 0.93 (0.52–1.64) 0.797 0.84 (0.49–1.43) 0.5187
Heart failure            
 Overall adjusted comparison§ 0.015 0.018 0.279
 ES vs. MinS 3.07 (1.26–7.46) 0.0134 2.22 (1.34–3.68) 0.0021 1.52 (0.95–2.41) 0.0782
 ES vs. DS 3.67 (1.03–13.1) 0.0447 2.04 (1.04–4.02) 0.0389 1.60 (0.86–3.01) 0.141
 ES vs. ModS 3.62 (1.56–8.41) 0.0028 1.71 (1.08–2.72) 0.0228 1.43 (0.93–2.21) 0.1035
 ModS vs. MinS 0.85 (0.37–1.96) 0.6976 1.29 (0.85–1.97) 0.2274 1.06 (0.72–1.55) 0.7752
 ModS vs. DS 1.01 (0.30–3.43) 0.9834 1.19 (0.65–2.17) 0.5668 1.12 (0.64–1.97) 0.6961
 DS vs. MinS 0.84 (0.24–2.86) 0.7756 1.09 (0.58–2.02) 0.7936 0.94 (0.53–1.68) 0.8456
Stroke            
 Overall adjusted comparison§ 0.601 0.427 0.043
 ES vs. MinS 1.58 (0.58–4.32) 0.3681 1.42 (0.63–3.21) 0.4041 1.13 (0.51–2.50) 0.7714
 ES vs. DS 2.18 (0.51–9.34) 0.2947 2.83 (0.81–9.91) 0.1048 4.33 (1.19–15.7) 0.0259
 ES vs. ModS 1.84 (0.70–4.84) 0.2154 1.26 (0.58–2.73) 0.5659 0.83 (0.38–1.78) 0.6311
 ModS vs. MinS 0.86 (0.36–2.04) 0.7325 1.13 (0.61–2.09) 0.7026 1.36 (0.78–2.35) 0.2759
 ModS vs. DS 1.18 (0.30–4.61) 0.8089 2.25 (0.74–6.88) 0.1551 5.22 (1.67–16.4) 0.0046
 DS vs. MinS 0.73 (0.19–2.84) 0.6472 0.50 (0.16–1.57) 0.2359 0.26 (0.08–0.81) 0.0197
Cardiovascular mortality            
 Overall adjusted comparison§ 0.768
 ES vs. MinS 0.91 (0.45–1.81) 0.7786
 ES vs. DS 1.33 (0.52–3.40) 0.5545
 ES vs. ModS 1.10 (0.56–2.18) 0.7828
 ModS vs. MinS 0.82 (0.50–1.36) 0.449
 ModS vs. DS 1.21 (0.54–2.68) 0.6454
 DS vs. MinS 0.68 (0.31–1.51) 0.3451

Definition of abbreviations: BMI = body mass index; CI = confidence interval; DS = disturbed sleepy; ES = excessively sleepy; HDL = high-density lipoprotein; HR = hazard ratio; MinS = minimally symptomatic; ModS = moderately sleepy; OR = odds ratio.

Values in bold represent significant differences in pairwise comparisons.

*

Logistic regression model adjusted for age, sex, BMI, type 2 diabetes, hypertension, HDL, total cholesterol, triglycerides, apnea–hypopnea index, alcohol use, smoking status, race, ethnicity, and use of lipid-lowering medication.

Cox proportional hazards regression model adjusted for age, sex, BMI, type 2 diabetes, hypertension, HDL, total cholesterol, triglycerides, apnea–hypopnea index, alcohol use, smoking status, race, ethnicity, and use of lipid-lowering medication, excluding individuals with the corresponding disease at baseline.

Cox proportional hazards regression model adjusted for age, sex, BMI, type 2 diabetes, hypertension, HDL, total cholesterol, triglycerides, apnea–hypopnea index, alcohol use, smoking status, race, ethnicity, use of lipid-lowering medication, and status of corresponding disease at baseline. The reference category for all comparisons is always the second category presented in the column “Pairwise Comparison.” Results of the tests of proportional-hazards assumption are presented in Table E7.

§

P values evaluating null hypothesis of no differences in risk among subtypes.